Clinical Trials Browser

Carcinoma, Hepatocellular, Neoplasm Metastasis

NCT00208260 2026-02-05

Intensified Chemotherapy in CRC After Resection of Liver Metastases

Phase 2/3 Completed

124 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT05153785 2026-01-15

Perioperative Intravenous Lidocaine in Liver Surgery

Phase 2/3 Completed

124 enrolled

Gastrointestinal

Liver Neoplasms, Pain, Postoperative

NCT05215379 2026-01-02

Neoadjuvant Chemoradiation Therapy Combined With Immunotherapy for MSS Ultra-low Rectal Cancer

Phase 2/3 Completed

201 enrolled

Gastrointestinal

Rectal Neoplasms

NCT04082364 2025-06-08

MAHOGANY

Phase 2/3 Completed

82 enrolled 22 charts

Gastrointestinal

Stomach Neoplasms

NCT01249352 2025-03-31

NICE

Phase 2/3 Completed

104 enrolled

Gastrointestinal

Adenocarcinoma, Esophageal Neoplasms

NCT04499924 2025-01-22

MOUNTAINEER-02

Phase 2/3 Completed

17 enrolled 23 charts

Gastrointestinal

Adenocarcinoma Of Esophagus

NCT02494973 2024-10-28

PACHA-01

Phase 2/3 Completed

104 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT01404156 2024-08-28

POWERRANGER

Phase 2/3 Completed

29 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms

NCT02746796 2024-05-03

Study of ONO-4538 in Gastric Cancer

Phase 2/3 Completed

680 enrolled

Gastrointestinal

Stomach Neoplasms

NCT03600831 2024-01-09

Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma

Phase 2/3 Completed

434 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03607656 2023-12-18

CHANGE

Phase 2/3 Completed

270 enrolled

Gastrointestinal

Stomach Neoplasms

NCT03414983 2023-11-18

CheckMate 9X8

Phase 2/3 Completed

196 enrolled 26 charts

Gastrointestinal

Colorectal Neoplasms

NCT02608203 2022-10-14

GEP-NOC

Phase 2/3 Completed

18 enrolled

EndocrineGastrointestinalNET

Gastroenteropancreatic Neuroendocrine Tumors

NCT03281096 2022-07-27

A Research of Berberine Hydrochloride to Prevent Colorectal Adenomas in Patients With Previous Colorectal Cancer

Phase 2/3 Completed

1,000 enrolled

Gastrointestinal

Colorectal Adenomas

NCT02661971 2022-07-11

RAMSES/FLOT7

Phase 2/3 Completed

180 enrolled

Gastrointestinal

Stomach Neoplasms

NCT01164202 2022-03-18

SATURNE

Phase 2/3 Completed

78 enrolled 9 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02591030 2022-02-24

AMEBICA

Phase 2/3 Completed

191 enrolled

Gastrointestinal

Bile Duct Neoplasms

NCT01962246 2022-02-21

A-C

Phase 2/3 Completed

169 enrolled

Gastrointestinal

Gastroesophageal Junction Adenocarcinoma

NCT03130790 2022-02-15

Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line)

Phase 2/3 Completed

52 enrolled

Gastrointestinal

Stomach Neoplasms

NCT03093870 2021-08-03

TreeTopp

Phase 2/3 Completed

151 enrolled 18 charts

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasms

NCT00112658 2021-03-08

Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

Phase 2/3 Completed

342 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT02851784 2021-03-04

Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma

Phase 2/3 Completed

40 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT02195232 2021-03-03

CATIQ

Phase 2/3 Completed

64 enrolled 7 charts

GastrointestinalThoracic

Thromboembolism of Vein VTE in Colorectal Cancer

NCT03031444 2021-02-01

PARECEC

Phase 2/3 Completed

135 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT03556956 2020-12-08

Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer

Phase 2/3 Completed

219 enrolled

Gastrointestinal

Colorectal Cancer Metastatic

NCT00212615 2020-11-06

XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer

Phase 2/3 Completed

116 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT02172976 2020-09-02

Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma

Phase 2/3 Completed

40 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT02581462 2020-08-11

PETRARCA

Phase 2/3 Completed

81 enrolled

Gastrointestinal

Stomach Neoplasms

NCT02979691 2020-07-21

Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01

Phase 2/3 Completed

350 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT00952029 2020-03-30

Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer

Phase 2/3 Completed

492 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00272324 2020-03-13

Aspirin/Folate Prevention of Large Bowel Polyps

Phase 2/3 Completed

1,121 enrolled

Gastrointestinal

Adenoma, Polyps, Colorectal Neoplasms, Adenomatous Polyps

NCT01516944 2020-02-13

Perioperative Chemotherapy for Potentially Resectable Gastric Cancer

Phase 2/3 Completed

749 enrolled

Gastrointestinal

Stomach Neoplasms

NCT01348217 2020-01-27

CONCORDE

Phase 2/3 Completed

196 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT01216644 2019-06-19

5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer

Phase 2/3 Completed

716 enrolled

Gastrointestinal

Pathologic Complete Response, Stomach Neoplasms

NCT02332499 2019-05-21

ALTER0703

Phase 2/3 Completed

419 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT01550055 2019-04-10

CRC009

Phase 2/3 Completed

512 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT03239184 2019-01-25

Bioinformation Therapy for Pancreatic Cancer

Phase 2/3 Completed

120 enrolled

Gastrointestinal

Unresectable Pancreatic Cancer

NCT03350477 2019-01-25

Bioinformation Therapy for Gastric Cancer

Phase 2/3 Completed

120 enrolled

Gastrointestinal

Advanced Gastric Cancer

NCT01458717 2018-05-02

Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer

Phase 2/3 Completed

58 enrolled

Gastrointestinal

Neoplasms, Pancreatic Neoplasms, Recurrence

NCT02284139 2018-04-23

Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects

Phase 2/3 Completed

90 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Pancreatic Neoplasms, Colorectal Neoplasms

NCT01932385 2018-02-14

Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma

Phase 2/3 Completed

86 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03428529 2018-02-09

INCAGI004

Phase 2/3 Completed

63 enrolled

Gastrointestinal

Rectal Neoplasms

NCT00587600 2017-11-22

BIOBAR

Phase 2/3 Completed

208 enrolled

Gastrointestinal

Barrett Esophagus

NCT01901692 2017-09-18

START

Phase 2/3 Completed

90 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02829359 2017-06-12

HBV-DNA(-)

Phase 2/3 Completed

200 enrolled

Gastrointestinal

Liver Neoplasms

NCT00160875 2017-05-04

Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer

Phase 2/3 Completed

54 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT00384176 2017-04-14

HORIZON III

Phase 2/3 Completed

1,814 enrolled 13 charts

Gastrointestinal

Colorectal Neoplasms

NCT01523431 2017-03-30

Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients

Phase 2/3 Completed

583 enrolled

Gastrointestinal

Diarrhea, Neutropenia, Colorectal Neoplasms

NCT00153816 2017-03-15

Vitamin D/Calcium Polyp Prevention Study

Phase 2/3 Completed

2,813 enrolled 15 charts

Gastrointestinal

Adenoma, Polyps, Colorectal Neoplasms, Adenomatous Polyps

Clinical Trials

TRIPLET

Intensified Chemotherapy in CRC After Resection of Liver Metastases

Perioperative Intravenous Lidocaine in Liver Surgery

Neoadjuvant Chemoradiation Therapy Combined With Immunotherapy for MSS Ultra-low Rectal Cancer

MAHOGANY

NICE

MOUNTAINEER-02

PACHA-01

POWERRANGER

Study of ONO-4538 in Gastric Cancer

Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma

CHANGE

CheckMate 9X8

GEP-NOC

A Research of Berberine Hydrochloride to Prevent Colorectal Adenomas in Patients With Previous Colorectal Cancer

RAMSES/FLOT7

SATURNE

AMEBICA

A-C

Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line)

TreeTopp

Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular Carcinoma

CATIQ

PARECEC

Masitinib in Combination With FOLFIRI in Third or Fourth Line of Treatment of Patients With Metastatic Colorectal Cancer

XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer

Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma

PETRARCA

Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01

Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer

Aspirin/Folate Prevention of Large Bowel Polyps

Perioperative Chemotherapy for Potentially Resectable Gastric Cancer

CONCORDE

5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer

ALTER0703

CRC009

Bioinformation Therapy for Pancreatic Cancer

Bioinformation Therapy for Gastric Cancer

Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer

Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects

Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma

INCAGI004

BIOBAR

START

HBV-DNA(-)

Pre-operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer

HORIZON III

Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients

Vitamin D/Calcium Polyp Prevention Study